Literature DB >> 10448041

The structure of pyruvate kinase from Leishmania mexicana reveals details of the allosteric transition and unusual effector specificity.

D J Rigden1, S E Phillips, P A Michels, L A Fothergill-Gilmore.   

Abstract

Glycolysis occupies a central role in cellular metabolism, and is of particular importance for the catabolic production of ATP in protozoan parasites such as Leishmania and Trypanosoma. In these organisms pyruvate kinase plays a key regulatory role, and is unique in responding to fructose 2,6-bisphosphate as allosteric activator. The determination of the first eukaryotic pyruvate kinase crystal structure in the T-state is reported. A comparison of the leishmania and yeast R-state enzymes reveals fewer differences than the previous comparison of Escherichia coli T-state and rabbit muscle non-allosteric enzymes. Structural changes related to the allosteric transition can therefore be distinguished from those that are a consequence of the inherent wide structural divergence between bacterial and mammalian proteins. The allosteric transition involves significant changes in a tightly packed array of eight alpha helices at the interface near the catalytic site. At the other interface the allosteric transition appears to be accompanied by the bending of a ten-stranded intersubunit beta sheet adjacent to the effector site. Helix Calpha1 makes contacts to the N-terminal helical domain and bridges both interfaces. A comparison of the effector sites of the leishmania and yeast enzymes reveals the structural basis for the different effector specificity. Two loops comprising residues 443-453 and 480-489 adopt very different conformations in the two enzymes, and Lys453 and His480 that are a feature of trypanosomatid enzymes provide probable ligands for the 2-phospho group of the effector molecule. These differences offer an opportunity for the design of drugs that would bind to the trypanosomatid enzymes but not to those of the mammalian host. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10448041     DOI: 10.1006/jmbi.1999.2918

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  24 in total

1.  A novel GDP-dependent pyruvate kinase isozyme from Toxoplasma gondii localizes to both the apicoplast and the mitochondrion.

Authors:  Tomoya Saito; Manami Nishi; Muoy I Lim; Bo Wu; Takuya Maeda; Hisayuki Hashimoto; Tsutomu Takeuchi; David S Roos; Takashi Asai
Journal:  J Biol Chem       Date:  2008-03-06       Impact factor: 5.157

2.  Allosteric mechanism of pyruvate kinase from Leishmania mexicana uses a rock and lock model.

Authors:  Hugh P Morgan; Iain W McNae; Matthew W Nowicki; Véronique Hannaert; Paul A M Michels; Linda A Fothergill-Gilmore; Malcolm D Walkinshaw
Journal:  J Biol Chem       Date:  2010-02-01       Impact factor: 5.157

3.  The trypanocidal drug suramin and other trypan blue mimetics are inhibitors of pyruvate kinases and bind to the adenosine site.

Authors:  Hugh P Morgan; Iain W McNae; Matthew W Nowicki; Wenhe Zhong; Paul A M Michels; Douglas S Auld; Linda A Fothergill-Gilmore; Malcolm D Walkinshaw
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

4.  Molecular replacement with a large number of molecules in the asymmetric unit.

Authors:  Chacko Jobichen; Kunchithapadam Swaminathan
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-08-27       Impact factor: 1.056

Review 5.  What Mutagenesis Can and Cannot Reveal About Allostery.

Authors:  Gerald M Carlson; Aron W Fenton
Journal:  Biophys J       Date:  2016-05-10       Impact factor: 4.033

6.  Methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as a target for bis-indole alkaloids with antibacterial activities.

Authors:  Roya Zoraghi; Liam Worrall; Raymond H See; Wendy Strangman; Wendy L Popplewell; Huansheng Gong; Toufiek Samaai; Richard D Swayze; Sukhbir Kaur; Marija Vuckovic; B Brett Finlay; Robert C Brunham; William R McMaster; Michael T Davies-Coleman; Natalie C Strynadka; Raymond J Andersen; Neil E Reiner
Journal:  J Biol Chem       Date:  2011-10-26       Impact factor: 5.157

7.  Identification of pyruvate kinase in methicillin-resistant Staphylococcus aureus as a novel antimicrobial drug target.

Authors:  Roya Zoraghi; Raymond H See; Peter Axerio-Cilies; Nag S Kumar; Huansheng Gong; Anne Moreau; Michael Hsing; Sukhbir Kaur; Richard D Swayze; Liam Worrall; Emily Amandoron; Tian Lian; Linda Jackson; Jihong Jiang; Lisa Thorson; Christophe Labriere; Leonard Foster; Robert C Brunham; William R McMaster; B Brett Finlay; Natalie C Strynadka; Artem Cherkasov; Robert N Young; Neil E Reiner
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

8.  Identification of regions of rabbit muscle pyruvate kinase important for allosteric regulation by phenylalanine, detected by H/D exchange mass spectrometry.

Authors:  Charulata B Prasannan; Maria T Villar; Antonio Artigues; Aron W Fenton
Journal:  Biochemistry       Date:  2013-03-06       Impact factor: 3.162

9.  Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo; Bertil Glader; Hitoshi Kanno; Archana Agarwal; Wilma Barcellini; Stefan Eber; James D Hoyer; David J Kuter; Tabita Magalhães Maia; Maria Del Mar Mañu-Pereira; Theodosia A Kalfa; Serge Pissard; José-Carlos Segovia; Eduard van Beers; Patrick G Gallagher; David C Rees; Richard van Wijk
Journal:  Am J Hematol       Date:  2018-11-28       Impact factor: 10.047

10.  Crystallization and preliminary X-ray analysis of pyruvate kinase from Bacillus stearothermophilus.

Authors:  Kenichiro Suzuki; Sohei Ito; Akiko Shimizu-Ibuka; Hiroshi Sakai
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.